Related Experiment Video
Updated: Aug 10, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Genetic Effects on the Correlation Structure of CVD Risk Factors: Exome-Wide Data From a Ghanaian Population
Nuri Kodaman1, Rafal S Sobota2, Folkert W Asselbergs3
1Vanderbilt Genetics Institute, Vanderbilt University Medical School, Nashville, TN, USA; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA; Department of Genetics, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
Insights
Genetic variants significantly alter the relationship between plasminogen activator inhibitor-1 (PAI-1) and cardiovascular disease risk factors. This finding helps explain PAI-1 heritability and identifies potential targets for blood pressure management.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Biochemistry
Background:
- Plasma plasminogen activator inhibitor-1 (PAI-1) concentration is linked to cardiovascular disease (CVD) risk factors and directly impacts thrombosis.
- PAI-1's high heritability is not fully explained by genetic association studies, suggesting a role for its relationship with CVD risk factors.
- Genetic variants may modulate the connection between PAI-1 and CVD risk factors, offering clinical and biological insights.
Purpose of the Study:
- To investigate genetic variants that modify the correlation between PAI-1 and key CVD risk factors.
- To explore how genotype influences the relationship between PAI-1 and cardiovascular health.
- To identify genetic loci affecting the interplay between PAI-1 and risk factors like body mass index, triglycerides, mean arterial pressure, and fasting glucose.
Main Methods:
- Exome-wide data analysis of 1,032 Ghanaian participants.
- Testing for heterogeneity of correlation by genotype between PAI-1 and four CVD risk factors.
- Utilizing univariate and multivariate statistical tests to assess genetic associations.
Main Results:
- Significant heterogeneities of correlation by genotype were observed between PAI-1 and CVD risk factors, exceeding marginal effects.
- No evidence of type I inflation was found, supporting the robustness of the findings.
- The strongest association was the heterogeneity of correlation between PAI-1 and mean arterial pressure at rs10738554, near the SLC24A2 gene.
Conclusions:
- Genetic variations play a crucial role in modulating the relationship between PAI-1 and cardiovascular risk factors.
- The identified genetic locus near SLC24A2 is a significant factor in the PAI-1 and mean arterial pressure correlation.
- These findings contribute to understanding PAI-1 heritability and may inform strategies for managing blood pressure and CVD risk.
Abstract:
Plasma concentration of plasminogen activator inhibitor-1 (PAI-1) is highly correlated with several cardiovascular disease (CVD) risk factors. It also plays a direct role in CVD, including myocardial infarction and stroke, by impeding the dissolution of thrombi in the blood. Insofar as PAI-1 links CVD's risk factors to its endpoints, genetic variants modulating the relationship between PAI-1 and risk factors may be of particular clinical and biological interest. The high heritability of PAI-1, which has not been explained by genetic association studies, may also, in large part, be due to this relationship with CVD risk factors. Using exome-wide data from 1,032 Ghanaian study participants, we tested for heterogeneity of correlation by genotype between PAI-1 and 4 CVD risk factors (body mass index, triglycerides, mean arterial pressure, and fasting glucose) under the hypothesis that loci involved in the relationship between PAI-1 and other risk factors will also modify their correlational structure. We found more significant heterogeneities of correlation by genotype than we found marginal effects, with no evidence of type I inflation. The most significant result among all univariate and multivariate tests performed in this study was the heterogeneity of correlation between PAI-1 and mean arterial pressure at rs10738554, near SLC24A2, a gene previously associated with high blood pressure in African Americans.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
Confounding in Epidemiological Studies
Bias in Epidemiological Studies
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genetic Variation
Genes exist in different versions called alleles, which...
